Jérôme A.
- Country
- France
- Department
- Service de Psychiatrie Adulte
Research Overview
- Long-term Evaluation of NMRA-335140 for Safety and Efficacy in Major Depressive Disorder Patients
- Evaluation of NMRA-335140 Efficacy in Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
- Long-term Safety Evaluation of Iclepertin in Schizophrenia Patients Post-Completion of Phase III Trials
Data & Insights
Has run more than one trial at 79 of 203 partner sites.
Specializations
Psychiatric Disorders
The investigator specializes in the therapeutic management of severe psychiatric conditions, with particular emphasis on schizophrenia and its associated cognitive impairments. Their research encompasses novel therapeutic approaches for improving outcomes in schizophrenia patients.
- Antipsychotic medications
- Cognitive dysfunction in schizophrenia
- Long-term treatment outcomes
Their work includes evaluation of innovative treatment formulations and comparative assessment of therapeutic interventions.
Mood Disorders
The investigator focuses on treating major depressive disorder (MDD), including specialized research in cases with anhedonia. Their expertise extends to investigating novel therapeutic approaches and adjunctive treatments for depression.
- Treatment-resistant depression
- Antidepressant augmentation strategies
- Relapse prevention
Their research includes long-term safety and efficacy evaluations of new therapeutic compounds for depression management.
Therapeutic Innovation
The investigator conducts research on novel pharmacological approaches, including kappa opioid receptor antagonists and new therapeutic compounds. Their work encompasses both short-term efficacy and long-term safety assessments.
- Novel drug mechanisms
- Bioavailability studies
- Extended safety evaluations
Their research contributes to the development of innovative treatment options for psychiatric disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.